A one-size-fits-all approach just doesn’t work for everyone, so we’ve developed a range of Oncomine assays to cover the spectrum of panel sizes and purposes.
Ion Torrent Oncomine tumor-specific panels complement Oncomine assays, providing end-to-end solutions for researching the molecular profile of specific tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples.
These dynamic panels are created from a curated inventory of pre-tested genes relevant to cancer research and sized to be economical (15–30 genes).
25-gene panel applicable to urothelial carcinoma (~90% of bladder cancers). Contains genes such as PIK3CA, FGFR3, and ERBB2.
15-gene panel applicable to renal cell carcinomas (the majority of kidney cancers). Contains genes such as VHL, MTOR, and PBRM1
15-gene panel containing BRCA1 and BRCA2 as well as HR pathway genes important for ovarian, breast, and prostate cancer research. Contains genes such as ATM, PALB2, and BRIP1.
22-gene panel applicable to hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Contains genes such as TP53, MYC, TERT, and CTNNB1.
24-gene panel applicable to colorectal and pancreatic adenocarcinoma, including DNA mismatch repair pathway genes. Also contains genes such as APC, KRAS, and NRAS.
25-gene panel applicable to non-Hodgkin’s lymphomas (primarily diffuse large B cell (DLBCL)) as well as to Hodgkin’s lymphoma. Contains genes such as BCL2, MYD88, and CARD11.
17-gene panel applicable to gastric, esophageal, and gastroesophageal adenocarcinoma. Contains genes such as TP53, ERBB2, and CDKN2A.
29-gene panel applicable to cutaneous and uveal melanoma. Contains genes such as BRAF, NRAS, and CDKN2A.
19-gene panel applicable to endometrial, cervical, and ovarian carcinomas. Contains genes such as PTEN, BRCA2, and CTNNB1.
21-gene panel applicable to prostate adenocarcinoma. Contains genes such as AR, PTEN, and MYC.
49-gene research panel complements the Oncomine tumor specific panels; however, it is not available with the Oncomine Lymphoma Panel. This RNA-only panel uses FusionSync technology to detect known, novel, and rare fusions from even small sample inputs. This panel cannot be customized.
28-gene panel containing homologous recombination repair (HRR) pathway genes. Inclusive of genes found on the Oncomine BRCA Expanded Panel plus additional non-HRR genes such as KRAS and PIK3CA important for ovarian, breast, prostate, and pancreatic cancer research.*
*The HRR Pathway Predesigned Panel does not come with a preconfigured Ion Reporter analysis workflow.
Oncomine tumor specific panels are available for any lab to order through ampliseq.com.
For Research Use Only. Not for use in diagnostic procedures.